Cargando…

High-Dose Inhaled Nitric Oxide as Adjunct Therapy in Cystic Fibrosis Targeting Burkholderia multivorans

BACKGROUND: Individuals with cystic fibrosis (CF) have persistent lung infections, necessitating the frequent use of antibiotics for pulmonary exacerbations. Some respiratory pathogens have intrinsic resistance to the currently available antibiotics, and any pathogen may acquire resistance over time...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartley, Bethany L., Gardner, Kelly J., Spina, Stefano, Hurley, Bryan P., Campeau, David, Berra, Lorenzo, Yonker, Lael M., Carroll, Ryan W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334765/ https://www.ncbi.nlm.nih.gov/pubmed/32685229 http://dx.doi.org/10.1155/2020/1536714

Ejemplares similares

Identification of two distinct phylogenomic lineages and model strains for the understudied cystic fibrosis lung pathogen Burkholderia multivorans
por: Parfitt, Kasia M., et al.
Publicado: (2023)

Identification and characterization of Burkholderia multivorans CCA53
por: Akita, Hironaga, et al.
Publicado: (2017)

Long-Term Evolution of Burkholderia multivorans during a Chronic Cystic Fibrosis Infection Reveals Shifting Forces of Selection
por: Silva, Inês N., et al.
Publicado: (2016)

PCR detection of Burkholderia multivorans in water and soil samples
por: Peeters, Charlotte, et al.
Publicado: (2016)

Comparative Evolutionary Patterns of Burkholderia cenocepacia and B. multivorans During Chronic Co-infection of a Cystic Fibrosis Patient Lung
por: Hassan, A. Amir, et al.
Publicado: (2020)

Genomics of an endemic cystic fibrosis Burkholderia multivorans strain reveals low within-patient evolution but high between-patient diversity
por: Lood, Cédric, et al.
Publicado: (2021)

Focusing on the penultimate step: increasing early lung transplant discussion in cystic fibrosis clinic to prepare patients for referral
por: Bartley, Bethany L, et al.
Publicado: (2020)

Draft Genome Sequences of Two Burkholderia multivorans Sequential Isolates from a Chronic Lung Infection of a Cystic Fibrosis Patient
por: Silva, Inês N., et al.
Publicado: (2015)

Proteomic Studies of the Biofilm Matrix including Outer Membrane Vesicles of Burkholderia multivorans C1576, a Strain of Clinical Importance for Cystic Fibrosis
por: Terán, Lucrecia C., et al.
Publicado: (2020)

Burkholderia multivorans: A rare yet emerging cause of bacterial meningitis
por: Peralta, Diego P., et al.
Publicado: (2018)

Sequence heterogeneity of the PenA carbapenemase in clinical isolates of Burkholderia multivorans
por: Becka, Scott A., et al.
Publicado: (2018)

Inhibition of Burkholderia multivorans Adhesion to Lung Epithelial Cells by Bivalent Lactosides
por: Wright, Ciara, et al.
Publicado: (2012)

Genomic Sequence of Burkholderia multivorans NKI379, a Soil Bacterium That Inhibits the Growth of Burkholderia pseudomallei
por: Hsueh, Pei-Tan, et al.
Publicado: (2015)

Survey of Bartonella spp. in U.S. Bed Bugs Detects Burkholderia multivorans but Not Bartonella
por: Saenz, Virna L., et al.
Publicado: (2013)

Multifrequency STD NMR Unveils the Interactions of Antibiotics With Burkholderia multivorans Biofilm Exopolysaccharide
por: Nepravishta, Ridvan, et al.
Publicado: (2021)

Immunoproteomic Analysis of Proteins Expressed by Two Related Pathogens, Burkholderia multivorans and Burkholderia cenocepacia, during Human Infection
por: Shinoy, Minu, et al.
Publicado: (2013)

Lung transplant referral practice patterns: a survey of cystic fibrosis physicians and general pulmonologists
por: Bartley, Bethany L., et al.
Publicado: (2020)

Comparative genomics of Burkholderia multivorans, a ubiquitous pathogen with a highly conserved genomic structure
por: Peeters, Charlotte, et al.
Publicado: (2017)

A Histone-Like Nucleoid Structuring Protein Regulates Several Virulence Traits in Burkholderia multivorans
por: Gomes, Sara C., et al.
Publicado: (2021)

A genome-wide association analysis reveals a potential role for recombination in the evolution of antimicrobial resistance in Burkholderia multivorans
por: Diaz Caballero, Julio, et al.
Publicado: (2018)

The classification of ATP‐binding cassette subfamily A member 3 mutations using the cystic fibrosis transmembrane conductance regulator classification system
por: Denman, Laura, et al.
Publicado: (2018)

Outbreak of Burkholderia multivorans among patients at two acute-care hospitals in California, August 2021–July 2022
por: McNamara, Kiara, et al.
Publicado: (2023)

Therapeutic Effects of Inhaled Nitric Oxide Therapy in COVID-19 Patients
por: Kamenshchikov, Nikolay O., et al.
Publicado: (2022)

Eradication of Burkholderia cepacia complex in cystic fibrosis patients with inhalation of amiloride and tobramycin combined with oral cotrimoxazole
por: Akkerman-Nijland, Anne M., et al.
Publicado: (2023)

Characteristics of Organic Acid Secretion Associated with the Interaction between Burkholderia multivorans WS-FJ9 and Poplar Root System
por: Li, Guan-Xi, et al.
Publicado: (2018)

Febrile urinary tract infection in an immunocompetent male caused by Burkholderia multivorans- evidence of transmission in a home hot tub
por: Rasmussen, Magnus, et al.
Publicado: (2019)

Burkholderia multivorans requires species‐specific GltJK for entry of a contact‐dependent growth inhibition system protein
por: Myers‐Morales, Tanya, et al.
Publicado: (2021)

Disparate properties of Burkholderia multivorans and Pseudomonas aeruginosa regarding outer membrane chemical permeabilization to the hydrophobic substances novobiocin and triclosan
por: Ruskoski, Sallie A., et al.
Publicado: (2023)

Burkholderia species in human infections in Mexico: Identification of B. cepacia, B. contaminans, B. multivorans, B. vietnamiensis,B. pseudomallei and a new Burkholderia species
por: Meza-Radilla, Georgina, et al.
Publicado: (2021)

Burkholderia pseudomallei in cystic fibrosis and treatment complications
por: Radhakrishna, Naghmeh, et al.
Publicado: (2015)

Burkholderia cepacia complex in Indian cystic fibrosis patients
por: Gautam, Vikas, et al.
Publicado: (2012)

Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis
por: Howlin, Robert P., et al.
Publicado: (2017)

Inhaled Biologicals for the Treatment of Cystic Fibrosis
por: Sala, Valentina, et al.
Publicado: (2019)

Identification, cloning and expression patterns of the genes related to phosphate solubilization in Burkholderia multivorans WS-FJ9 under different soluble phosphate levels
por: Liu, Yu-Qing, et al.
Publicado: (2020)

Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation
por: Rakhshan, Amin, et al.
Publicado: (2023)

Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada
por: Speert, David P., et al.
Publicado: (2002)

Burkholderia cepacia complex: clinical course in cystic fibrosis patients
por: Folescu, Tania Wrobel, et al.
Publicado: (2015)

Understanding the Pathogenicity of Burkholderia contaminans, an Emerging Pathogen in Cystic Fibrosis
por: Nunvar, Jaroslav, et al.
Publicado: (2016)

Genetic similarity of Burkholderia cenocepacia from cystic fibrosis patients
por: Pretto, Luana, et al.
Publicado: (2013)

Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients
por: Garcia, Bryan A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_469l8dcda16p0fp2p00uv5dt61